Drugs / TECHNETIUM TC-99M TROFOLASTAT CHLORIDE

Trials 5

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 13 trials
Phase 1 NCT01654874 Jul 2012 → Feb 2013 prostate cancer Molecular Insight Pharmaceuticals, Inc. Completed No outcome recorded
Phase 1 NCT01615406 Apr → Nov 2012 prostate cancer Molecular Insight Pharmaceuticals, Inc. Completed No outcome recorded
Phase 1 NCT01572701 Jan → Jun 2012 prostate cancer Molecular Insight Pharmaceuticals, Inc. Completed No outcome recorded
Phase 21 trial
Phase 2 NCT01667536 Aug 2012 → Dec 2013 prostate cancer Molecular Insight Pharmaceuticals, Inc. Completed No outcome recorded
Phase 31 trial
Phase 3 NCT02615067 Dec 2015 → Dec 2017 prostate cancer Molecular Insight Pharmaceuticals, Inc. Completed No outcome recorded

Evidence & citations 11 cited values

Every value below carries the sentence it was read from. 7 sources stand behind the page.

FieldValueCited text
Known as TECHNETIUM TC-99M TROFOLASTAT CHLORIDE ChEMBL registry synonym — accepted as the source's own label CHEMBL4297855 ↗
Known as 99mTc MIP 1404 “A Phase 1 Pilot Study of 99mTc-MIP-1404 SPECT/CT Imaging to Histology in Men With Prostate Cancer” NCT01615406 ↗
5

“A single dose of 20 ±3 mCi intravenous (IV) injection of 99mTc MIP 1404” NCT01615406 ↗

NCT01572701 ↗

NCT01654874 ↗

NCT01667536 ↗

NCT02615067 ↗

Known as Chlorure de technetium (99mtc) trofolastat ChEMBL registry synonym — accepted as the source's own label CHEMBL4297855 ↗
Known as Cloruro de tecnecio (99mtc) trofolastat ChEMBL registry synonym — accepted as the source's own label CHEMBL4297855 ↗
Known as F-1311 ChEMBL registry synonym — accepted as the source's own label CHEMBL4297855 ↗
Known as MIP TC-1404 ChEMBL registry synonym — accepted as the source's own label CHEMBL4297855 ↗
Known as MIP-99MTC-1404 ChEMBL registry synonym — accepted as the source's own label CHEMBL4297855 ↗
Known as Technetium (99mtc) trofolastat chloride ChEMBL registry synonym — accepted as the source's own label CHEMBL4297855 ↗
Action Inhibit “small-molecule inhibitors of PSMA” PMID 23733925 ↗ Jun 2013
Modality Diagnostic / imaging agent “Single Photon Emission Computed Tomography (SPECT)/CT Imaging” NCT01572701 ↗
Route Intravenous “20 (±3) mCi of study drug will be administered by IV injection as a slow bolus” NCT01572701 ↗